Anders Wallin

发表

Performance of EGNSS-Based Timing in Various Threat Conditions

Sanna Kaasalainen, Heidi Kuusniemi, Martti Kirkko-Jaakkola, 2020, IEEE Transactions on Instrumentation and Measurement.

Validation of a posturographic approach to monitor sleepiness.

Edward Hæggström, Anders Wallin, Pia Forsman, 2010, Journal of biomechanics.

Towards distributed fault-tolerant timekeeping based on a WR-network

Anders Wallin, 2018 .

Receiver-Level Robustness Concepts for EGNSS Timing Services

Sanna Kaasalainen, Heidi Kuusniemi, Martti Kirkko-Jaakkola, 2017 .

Evaluating the Robustness of EGNSS Based Timing Services

Sanna Kaasalainen, Heidi Kuusniemi, Martti Kirkko-Jaakkola, 2017 .

Redundant secure timing sources and timing distribution to digital power protection and control applications

Anders Wallin, Harald Hauglin, Tim Dunker, 2020 .

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

Magda Tsolaki, Giovanni B. Frisoni, Min Kim, 2019, Alzheimer's & dementia.

Monte Carlo feature selection and rule-based models to predict Alzheimer’s disease in mild cognitive impairment

Jan Komorowski, Anders Wallin, Henrik Zetterberg, 2012, Journal of Neural Transmission.

Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment

Stefan J. Teipel, Ping He, Anders Wallin, 2007 .

Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.

Anders Wallin, Annika Olsson, Kaj Blennow, 2005, Clinical chemistry.

Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.

Anders Wallin, Henrik Zetterberg, Kaj Blennow, 2009, Journal of Alzheimer's disease : JAD.

B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia

Michael Fu, Daniel Kondziella, Anders Wallin, 2009, Neuroreport.

The Cognitive Assessment Battery (CAB): a rapid test of cognitive domains

Anders Wallin, Arto Nordlund, A. Nordlund, 2011, International Psychogeriatrics.

Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method

Anders Wallin, Dag Aarsland, Henrik Zetterberg, 2011, Neurochemical Research.

Amino-Truncated β-Amyloid42 Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild Cognitive Impairment

Anders Wallin, Annika Olsson, Kaj Blennow, 2005 .

Cystatin C in cerebrospinal fluid and multiple sclerosis

Anders Wallin, Henrik Zetterberg, Kaj Blennow, 2007, Annals of neurology.

Frontotemporal Dementia Can Be Distinguished from Alzheimer’s Disease and Subcortical White Matter Dementia by an Anterior-to-Posterior rCBF-SPET Ratio

Anders Wallin, Carsten Wikkelsö, M. Sjögren, 2000, Dementia and Geriatric Cognitive Disorders.

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

Johan Svensson, Anders Wallin, Henrik Zetterberg, 2016, Dementia and Geriatric Cognitive Disorders Extra.

Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.

Stefan Teipel, Ping He, Anders Wallin, 2007, Archives of general psychiatry.

Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia

Anders Wallin, Kaj Blennow, Andrej Tarkowski, 2002, Neurobiology of Aging.

An Alzheimer's disease-specific β-amyloid fragment signature in cerebrospinal fluid

Anders Wallin, Henrik Zetterberg, Kaj Blennow, 2006, Neuroscience Letters.

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

Anders Wallin, Henrik Zetterberg, Kaj Blennow, 2010, Neurobiology of Aging.

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

Anders Wallin, Björn Holmberg, Annika Olsson, 2005, Clinical chemistry.

Consensus guidelines for lumbar puncture in patients with neurological diseases

Bernhard Hemmer, Pedro Rosa-Neto, Jakub Hort, 2017, Alzheimer's & dementia.